These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 24142110

  • 21. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans.
    Duez H, Pavlic M, Lewis GF.
    Atheroscler Suppl; 2008 Sep; 9(2):33-8. PubMed ID: 18676184
    [Abstract] [Full Text] [Related]

  • 22. Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans.
    Xiao C, Dash S, Morgantini C, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1056-62. PubMed ID: 23471231
    [Abstract] [Full Text] [Related]

  • 23. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.
    Qin B, Qiu W, Avramoglu RK, Adeli K.
    Diabetes; 2007 Feb; 56(2):450-61. PubMed ID: 17259391
    [Abstract] [Full Text] [Related]

  • 24. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2966-74. PubMed ID: 10591677
    [Abstract] [Full Text] [Related]

  • 25. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR.
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [Abstract] [Full Text] [Related]

  • 26. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ, Heeks L, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PH, van Bockxmeer FM, Burnett JR.
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [Abstract] [Full Text] [Related]

  • 27. Intestinal SR-BI is upregulated in insulin-resistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins.
    Hayashi AA, Webb J, Choi J, Baker C, Lino M, Trigatti B, Trajcevski KE, Hawke TJ, Adeli K.
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G326-37. PubMed ID: 21546579
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.
    Diffenderfer MR, Brousseau ME, Millar JS, Barrett PH, Nartsupha C, Schaefer PM, Wolfe ML, Dolnikowski GG, Rader DJ, Schaefer EJ.
    J Lipid Res; 2012 Jun; 53(6):1190-9. PubMed ID: 22474066
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
    Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1672-8. PubMed ID: 18566298
    [Abstract] [Full Text] [Related]

  • 34. One day of mixed meal overfeeding reduces hepatic insulin sensitivity and increases VLDL particle but not VLDL-triglyceride secretion in overweight and obese men.
    Smith GI, Magkos F, Reeds DN, Okunade AL, Patterson BW, Mittendorfer B.
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3454-62. PubMed ID: 23750033
    [Abstract] [Full Text] [Related]

  • 35. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
    Welty FK, Lichtenstein AH, Barrett PH, Jenner JL, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821
    [Abstract] [Full Text] [Related]

  • 36. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH.
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [Abstract] [Full Text] [Related]

  • 37. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC, Lamarche B, Deshaies Y, Tremblay AJ, Bergeron J, Gagné C, Couture P.
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.
    Drouin-Chartier JP, Tremblay AJ, Lemelin V, Lépine MC, Lamarche B, Couture P.
    Diabetes Obes Metab; 2016 Dec; 18(12):1226-1235. PubMed ID: 27460541
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.